Novavax Signs Licensing Agreement With Pfizer for Vaccine Adjuvant Technology
Novavax, Inc. and Pfizer, Inc. have signed a licensing arrangement allowing Pfizer access to Novavax’s Matrix-M adjuvant technology to boost immune response to vaccines. The agreement will allow for use in vaccines targeting up to two infectious diseases.1 Novavax’s Matrix-M technology is an aluminum-free adjuvant designed to enhance the immune response in protein-based vaccines such […]
FDA Requires Vaccine Makers to Include Febrile Seizure Warning on Flu Shot Labels
The U.S. Food and Drug Administration (FDA) notified six influenza vaccine manufacturers on Jan. 9, 2026 that they must add a warning about the risk of febrile (fever) seizures to their product information labels, citing newly identified postmarketing safety data. The notices, issued under the FDA’s statutory authority to mandate safety labeling changes, were sent […]
Polio Vaccine Questioned by Chair of CDC Advisory Committee
In a podcast interview released on Jan. 22, 2026, pediatric cardiologist Kirk Milhoan, MD, PhD questioned the need for the polio vaccine.1 2 3 4 5 6 7 Dr. Milhoan, who is chair of the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP), said: As you look at polio, […]
CDC Scientist and Whistleblower Promoted to Research Vaccine Adverse Childhood Experiences
A senior researcher at the U.S. Centers for Disease Control and Prevention (CDC) William Thompson, PhD, who previously came forward in 2014 as a whistleblower claiming that the agency omitted statistically significant data related to MMR (measles-mumps-rubella)vaccine risks, has been promoted to oversee federal research into adverse experiences in childhood affecting long-term health outcomes for […]
CDC Changes Recommendations for Six Childhood Vaccines
The U.S. Department of Health and Human Services (DHHS) announced updates to the national childhood vaccine schedule involving six vaccines (rotavirus, COVID-19, influenza, meningococcal disease, hepatitis A, and hepatitis B) following a presidential memorandum directing the U.S. Centers for Disease Control and Prevention (CDC) to review and revise its recommendations. The changes clarify which vaccines […]
Moderna Secures CEPI Funding for mRNA Bird Flu Vaccine After U.S. Cancels Funding
Moderna secured new funding from an international organization for its experimental mRNA bird flu vaccine after the U.S. Department of Health and Human Services (DHHS) pulled back approximately $700 million in previously committed funding last year. The biotechnology company said that it will receive up to $54.3 million from the Coalition for Epidemic Preparedness Innovations […]